Northern Trust’s Synergy Pharmaceuticals SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-2,468,275
Closed -$281K – 4287
2018
Q4
$281K Sell
2,468,275
-602,674
-20% -$395K ﹤0.01% 3698
2018
Q3
$5.22M Buy
3,070,949
+129,219
+4% +$231K ﹤0.01% 2660
2018
Q2
$5.12M Buy
2,941,730
+8,711
+0.3% +$15.1K ﹤0.01% 2672
2018
Q1
$5.37M Buy
2,933,019
+18,935
+0.6% +$40K ﹤0.01% 2536
2017
Q4
$6.5M Buy
2,914,084
+157,639
+6% +$392K ﹤0.01% 2448
2017
Q3
$7.99M Sell
2,756,445
-48,323
-2% -$165K ﹤0.01% 2336
2017
Q2
$12.5M Buy
2,804,768
+372,683
+15% +$1.54M ﹤0.01% 2024
2017
Q1
$11.3M Buy
2,432,085
+341,312
+16% +$1.98M ﹤0.01% 2034
2016
Q4
$12.7M Buy
2,090,773
+86,477
+4% +$452K ﹤0.01% 1935
2016
Q3
$11M Sell
2,004,296
-7,460
-0.4% -$34.9K ﹤0.01% 2006
2016
Q2
$7.64M Buy
2,011,756
+900,432
+81% +$3.05M ﹤0.01% 2196
2016
Q1
$3.07M Sell
1,111,324
-7,664
-0.7% -$27.8K ﹤0.01% 2734
2015
Q4
$6.34M Buy
1,118,988
+51,454
+5% +$314K ﹤0.01% 2318
2015
Q3
$5.66M Buy
1,067,534
+30,044
+3% +$233K ﹤0.01% 2364
2015
Q2
$8.61M Buy
1,037,490
+38,434
+4% +$186K ﹤0.01% 2158
2015
Q1
$4.62M Sell
999,056
-1,101
-0.1% -$3.58K ﹤0.01% 2554
2014
Q4
$3.05M Sell
1,000,157
-42,250
-4% -$125K ﹤0.01% 2821
2014
Q3
$2.9M Buy
1,042,407
+110,897
+12% +$402K ﹤0.01% 2854
2014
Q2
$3.79M Sell
931,510
-92,412
-9% -$393K ﹤0.01% 2713
2014
Q1
$5.44M Sell
1,023,922
-113,139
-10% -$634K ﹤0.01% 2501
2013
Q4
$6.31M Buy
1,137,061
+26,566
+2% +$115K ﹤0.01% 2397
2013
Q3
$5M Buy
1,110,495
+273,298
+33% +$1.23M ﹤0.01% 2505
2013
Q2
$3.57M Buy
+837,197
New +$4.21M ﹤0.01% 2631

Other funds holding SGYP

Northern Trust's SGYP Position: Q1 2019 in Review

Northern Trust sold out of Synergy Pharmaceuticals (SGYP) in Q1 2019, closing a stake of 2,468,275 shares — an estimated $281K sold.

Northern Trust first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $12.7M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Northern Trust reported no remaining Synergy Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Northern Trust sold 2,468,275 Synergy Pharmaceuticals shares in Q1 2019, an estimated $281K.
  • Northern Trust first reported a position in Synergy Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • Northern Trust's Synergy Pharmaceuticals position peaked at $12.7M in Q4 2016.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q1 2019.

Based on Northern Trust's 13F filing for Q1 2019, filed 13 May 2019.